Exelon director awarded 442 deferred share units

Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.

Exelon Corp director Marjorie Rodgers received a compensation grant of 442 deferred phantom share equivalents of Exelon common stock at a reference price of $46.62 per equivalent. This increased her balance in the Exelon stock fund account under a multi-fund, non-qualified deferred compensation plan to 10,547 phantom share equivalents.

These phantom share equivalents will be settled for cash on a 1-for-1 basis when her service on the board of directors ends. The balance includes 91 additional phantom share equivalents that accrued automatically through dividend reinvestment in the plan.

Insider Trade Summary

Grant/Award: 442 shares

Grant/Award 1 txn

Insider Cheshire Marjorie Rodgers

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred phantom share equivalents	442	$46.62	$21K

Holdings After Transaction: Deferred phantom share equivalents — 10,547 contracts (Direct)

Footnotes (2)

1. F1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
2. F2. Balance includes 91 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Key Figures

Deferred phantom share award: 442 units Reference price per equivalent: $46.62 Total phantom share balance: 10,547 units +1 more

4 metrics

Deferred phantom share award 442 units Grant of deferred phantom share equivalents of Exelon common stock

Reference price per equivalent $46.62 Price used for the 442-unit grant

Total phantom share balance 10,547 units Deferred phantom share equivalents after the reported transaction

Dividend reinvestment units 91 units Additional phantom share equivalents from automatic dividend reinvestment

Key Terms

Deferred phantom share equivalents, non-qualified deferred compensation plan, automatic dividend reinvestment

3 terms

Deferred phantom share equivalents financial

"Deferred phantom share equivalents held in the reporting person's Exelon stock fund account"

non-qualified deferred compensation plan financial

"part of a multi-fund, non-qualified deferred compensation plan"

An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.

automatic dividend reinvestment financial

"accrued to the account through automatic dividend reinvestment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Exelon (EXC) director Marjorie Rodgers report?

Exelon director Marjorie Rodgers reported receiving 442 deferred phantom share equivalents of Exelon common stock as a compensation grant. These are bookkeeping entries tied to a non-qualified deferred compensation plan rather than currently tradable shares in the market.

What are deferred phantom share equivalents in the Exelon (EXC) filing?

Deferred phantom share equivalents are units that track Exelon’s common stock value inside a deferred compensation plan. They are not actual shares; they will be settled in cash on a 1-for-1 basis when the director’s board service terminates.

How many Exelon (EXC) phantom share equivalents does the director hold after this award?

After the award of 442 deferred phantom share equivalents, the director’s Exelon stock fund account shows a total balance of 10,547 phantom share equivalents. This total includes units earned from prior grants and additional units from automatic dividend reinvestment.

At what reference price were the new Exelon (EXC) phantom share equivalents granted?

The 442 new deferred phantom share equivalents were granted at a reference price of $46.62 per equivalent. This price is used to calculate the value of the compensation credited within the deferred compensation plan account.

How did dividend reinvestment affect the Exelon (EXC) director’s phantom share balance?

The director’s balance includes 91 additional phantom share equivalents accrued through automatic dividend reinvestment. When dividends are credited in the plan, they are converted into additional phantom share equivalents instead of being paid out in cash currently.

When will the Exelon (EXC) phantom share equivalents be paid out to the director?

The phantom share equivalents will be settled for cash on a 1-for-1 basis upon termination of the director’s service on Exelon’s board. Until then, the units remain as deferred compensation entries within the company’s non-qualified plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cheshire Marjorie Rodgers

(Last) (First) (Middle)

10 S DEARBORN STREET

54TH FLOOR

(Street)

CHICAGO ILLINOIS 60603

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred phantom share equivalents	(1)	06/30/2026		A		442		(1)	(1)	Common Stock	442	$46.62	10,547(2)	D

Explanation of Responses:

1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.

2. Balance includes 91 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Remarks:

	David T Skinner, attorney-in-fact for Marjorie Rodgers Cheshire	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)